Synairgen plc: Notice of Results | Company Announcements

Wednesday 02 September, 2009

Synairgen plc

Notice of Results

RNS Number : 3590Y

Synairgen plc

02 September 2009

SYNAIRGEN PLC

NOTICE OF RESULTS

Synairgen plc (LSE: SNG), the drug discovery and development company focused on asthma and chronic obstructive pulmonary disease ('COPD'), will be announcing its full year results for the year ended 30 June 2009 on Friday 4 September 2009.

Ends

For further information, please contact:

Synairgen

Tel: + 44 (0) 2380 512 800

Richard Marsden, Managing Director

John Ward, Finance Director

or email info@synairgen.com

Threadneedle Communications Tel: + 44 (0) 20 7653 9850

Graham Herring

graham.herring@threadneedlepr.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORLBMATMMAMBRL

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.